Consun Pharmaceutical Group has announced a share buyback transaction. The company executed a repurchase of its own shares on June 2nd, 2026.
For this transaction, a total of 203,000 shares were acquired. The total expenditure for the share repurchase amounted to HK$2.9154 million.
CONSUN PHARMA (HKEX: 01681)
The company confirmed the details of this buyback activity through a formal corporate announcement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments